Provided by Tiger Trade Technology Pte. Ltd.

Ensysce Biosciences Inc.

0.3950
-0.0048-1.20%
Post-market: 0.39520.0002+0.05%19:30 EDT
Volume:173.96K
Turnover:69.81K
Market Cap:7.69M
PE:-0.14
High:0.4266
Open:0.4100
Low:0.3930
Close:0.3998
52wk High:2.75
52wk Low:0.2300
Shares:19.46M
Float Shares:18.38M
Volume Ratio:0.81
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7523
EPS(LYR):-3.9790
ROE:-1295.09%
ROA:-185.51%
PB:-9.83
PE(LYR):-0.10

Loading ...

Jan 31, 2023

Major Issues Report

8-K - Current report
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Correspondence

CORRESP [Cover] - Correspondence
Jan 13, 2023

Major Issues Report

8-K - Current report
Dec 27, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2022

Major Issues Report

8-K - Current report
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 05, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 01, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 18, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 17, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 27, 2022

Major Issues Report

8-K - Current report
Sep 20, 2022

Major Issues Report

8-K - Current report